Nektar boosts authorized shares to 390M, completes 1-for-15 reverse split effective June 8

NEKTAR THERAPEUTICS

Authorized common shares increased from 300M to 390M, effective June 6, 2025, stockholder-approved May 23, 2025.
Reverse stock split at 1-for-15 ratio effective 11:59 p.m. ET June 8; split-adjusted trading starts June 9 under NKTR.
Fractional shares rounded up at DTC for directly held shares; rounded down to nearest whole share for equity awards.
Total authorized shares remain at 390M after reverse split due to prior increase.

item 5.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

NEKTAR THERAPEUTICS: Increased authorized common shares from 300M to 390M (effective 2025-06-06).

Change: charter amendment
Effective: 2025-06-06

Exact text from the filing

On June 6, 2025, Nektar Therapeutics (the “Company”) filed a Certificate of Amendment to the Certificate of Incorporation of the Company (the “Increase in Authorized Shares Amendment”) with the Secretary of State of the State of Delaware to increase the number of authorized shares of the Company’s common stock, par value $0.0001 (the “Common Stock”), from 300,000,000 shares to 390,000,000 shares.

View on SEC.gov

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

NEKTAR THERAPEUTICS: Effected one-for-fifteen reverse stock split effective June 8, 2025 (effective 2025-06-08).

Change: charter amendment
Effective: 2025-06-08

Exact text from the filing

On June 6, 2025, the Company also filed a Certificate of Amendment to the Certificate of Incorporation of the Company (the “Reverse Stock Split Amendment”) with the Secretary of State of the State of Delaware to effect a reverse stock split of the Company’s Common Stock at a ratio of one-for-fifteen (the “Reverse Stock Split”).

View on SEC.gov

27 governance changes filed in the last 30 days. Browse all governance changes →

NEKTAR THERAPEUTICS filing history →

Source: SEC EDGAR

accession 0001213900-25-052141

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.